Emerging applications of radiomics in rectal cancer: State of the art and future perspectives

Figure 3 Distribution of the current focus in the industry. Currently 58% of research focuses on tumor response assessment to preoperative neo-adjuvant radiochemotherapy (nCRT) therapies or prediction of the long-term prognosis, of which most studies are about prediction of tumor response after nCRT. RC: Rectal cancer; nCRT: Neo-adjuvant radiochemotherapy.